Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.90 Insider Own47.54% Shs Outstand19.92M Perf Week-10.51%
Market Cap60.72M Forward P/E- EPS next Y-1.01 Insider Trans0.45% Shs Float13.85M Perf Month-30.09%
Income-15.43M PEG- EPS next Q- Inst Own8.47% Short Float2.81% Perf Quarter-51.06%
Sales0.00M P/S- EPS this Y-24.00% Inst Trans19.81% Short Ratio1.41 Perf Half Y-22.03%
Book/sh0.82 P/B2.79 EPS next Y-8.60% ROA-88.57% Short Interest0.39M Perf Year22.99%
Cash/sh0.66 P/C3.47 EPS next 5Y- ROE-104.35% 52W Range1.40 - 7.75 Perf YTD-66.76%
Dividend Est.- P/FCF- EPS past 5Y-63.30% ROI-94.03% 52W High-70.32% Beta0.19
Dividend TTM- Quick Ratio5.32 Sales past 5Y0.00% Gross Margin- 52W Low64.29% ATR (14)0.29
Dividend Ex-Date- Current Ratio5.32 EPS Y/Y TTM-48.76% Oper. Margin0.00% RSI (14)34.80 Volatility16.70% 10.76%
Employees17 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price14.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q11.04% Payout- Rel Volume0.28 Prev Close2.13
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume276.29K Price2.30
SMA20-16.91% SMA50-22.52% SMA200-34.66% Trades Volume79,995 Change7.98%
Apr-18-24 09:37AM
Apr-15-24 09:36AM
Apr-02-24 07:53AM
Mar-20-24 09:46AM
09:35AM Loading…
Mar-05-24 09:35AM
Feb-21-24 09:31AM
Feb-08-24 04:45PM
Feb-07-24 09:37AM
Feb-05-24 10:30PM
Jan-24-24 08:35AM
Jan-04-24 09:34AM
Dec-18-23 09:39AM
Dec-11-23 09:36AM
09:46AM Loading…
Nov-30-23 09:46AM
Nov-28-23 08:50AM
Nov-22-23 11:10AM
Nov-21-23 09:46AM
Nov-06-23 09:18AM
Oct-31-23 09:55AM
Oct-26-23 08:58AM
Oct-16-23 09:05AM
Oct-03-23 09:14AM
Oct-02-23 08:06AM
Sep-22-23 12:04PM
Sep-21-23 08:55AM
09:10AM Loading…
Sep-19-23 09:10AM
Sep-15-23 01:18PM
Sep-07-23 10:38AM
Sep-01-23 08:39AM
Aug-23-23 08:37AM
Aug-18-23 09:20AM
Aug-16-23 09:05AM
Jul-25-23 08:42AM
Jul-17-23 09:37AM
Jul-10-23 09:47AM
Jun-26-23 09:49AM
Jun-22-23 09:53AM
Jun-20-23 09:45AM
Jun-16-23 09:43AM
Jun-14-23 07:30AM
Jun-12-23 09:49AM
May-26-23 09:53AM
May-22-23 01:48PM
May-21-23 04:05PM
May-04-23 12:30PM
May-03-23 04:42PM
Apr-26-23 05:30PM
Apr-04-23 08:00AM
Mar-31-23 08:00AM
Mar-23-23 08:00AM
Mar-10-23 07:45PM
Mar-06-23 08:00AM
Feb-27-23 08:45AM
Feb-15-23 08:30AM
Feb-09-23 08:00AM
Feb-07-23 08:00AM
Jan-13-23 08:00AM
Jan-06-23 08:00AM
Dec-28-22 08:00AM
Dec-20-22 08:00AM
Dec-19-22 08:00AM
Dec-14-22 12:43PM
Dec-13-22 08:00AM
Dec-12-22 08:00AM
Nov-11-22 08:00AM
Oct-25-22 08:00AM
Oct-18-22 08:00AM
Sep-07-22 12:05PM
Aug-23-22 06:36AM
Aug-01-22 10:10AM
May-21-22 08:26AM
May-20-22 10:19AM
May-09-22 08:00AM
Apr-05-22 09:30AM
Mar-16-22 10:13AM
Mar-07-22 08:00AM
Feb-22-22 08:00AM
Feb-01-22 11:36AM
Jan-31-22 08:00AM
Jan-25-22 12:17PM
Jan-19-22 08:00AM
Jan-12-22 08:43AM
Jan-06-22 09:00AM
Jan-03-22 10:46AM
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hsu JasonDirectorDec 11 '23Buy4.6731,000144,894813,000Dec 12 06:25 PM
Hsu JasonDirectorDec 08 '23Buy4.8825,000122,025782,000Dec 12 06:25 PM
Hsu JasonDirectorSep 15 '23Buy2.497,00017,396757,000Sep 18 07:03 PM
Hsu JasonDirectorSep 14 '23Buy2.5810,00025,772750,000Sep 18 07:03 PM
Ng CareyDirectorSep 14 '23Buy2.5810,00025,76010,000Sep 15 06:27 PM
Hsu JasonDirectorSep 12 '23Buy2.8330,00084,864740,000Sep 18 07:03 PM
Adams Helen C.DirectorSep 12 '23Buy2.9613,00038,49213,000Sep 14 05:20 PM
Hsu JasonDirectorSep 11 '23Buy2.8925,00072,280710,000Sep 18 07:03 PM
Hsu JasonDirectorSep 08 '23Buy2.5310,00025,317685,000Sep 12 04:58 PM
BUCHAN MELISSA JANEDirectorSep 07 '23Buy2.4620,00049,22620,000Sep 11 05:18 PM
Marquet MagdaDirectorSep 06 '23Buy2.479,00022,21320,000Sep 08 05:46 PM
Marquet MagdaDirectorSep 05 '23Buy2.4710,00024,72211,000Sep 06 04:33 PM
Marquet MagdaDirectorAug 31 '23Buy2.011,0002,0101,000Sep 05 06:43 PM